Sustained Improvement in a Metastatic Colon Cancer Patient with FOLFIRI-Aflibercept after FOLFOX Failure

Publisher： Karger

E-ISSN： 1662-6575|8|3|487-492

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.8, Iss.3, 2015-11, pp. : 487-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Alternating mFOLFOX6 and FOLFIRI Regimens in the First-Line Treatment for Unresectable or Metastatic Colorectal Cancer (KSCC0701)

By  

Oncology, Vol. 84, Iss. 4, 2013-01 ,pp. : 233-239

Karger

Access to resources Recommend Favorite

5-Fluorouracil Leucovorin and Oxaliplatin (FOLFOX) in the Treatment of Metastatic Colon Cancer with Severe Liver Dysfunction

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 222-224

Karger

Access to resources Recommend Favorite

Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-08 ,pp. : 428-433

Karger

Access to resources Recommend Favorite

Efficient and Safe Application of a FOLFIRI/Bevacizumab Combination to a Patient with Locally Advanced Rectal Cancer and Severe Chronic Renal Failure

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 65-65

Karger

Access to resources Recommend Favorite

Fatal Acute Liver Failure as a Consequence of Regorafenib Treatment in a Metastatic Colon Cancer

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 790-794

Karger

Access to resources Recommend Favorite